CD4 and malaria: Thus, analyzing the effects of JES6-1 treatment on P. chabaudi malaria contributes to the efforts to understand the molecular mechanisms responsible for activation and regulation of the CD4+ T cell response to Plasmodium aiming to ameliorate the outcome of the disease.